​

AxoGen (AXGN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

AXGN Stock Forecast

AxoGen (AXGN) stock forecast, based on 18 Wall Street analysts, predicts a 12-month average price target of $37.43, with a high of $40.00 and a low of $34.00. This represents a 24.81% increase from the last price of $29.99.

$5 $12 $19 $26 $33 $40 High: $40 Avg: $37.43 Low: $34 Last Closed Price: $29.99

AXGN Stock Rating

AxoGen stock's rating consensus is Buy, based on 18 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 15 Buy (83.33%), 3 Hold (16.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 18 0 3 15 Strong Sell Sell Hold Buy Strong Buy

AXGN Price Target Upside V Benchmarks

TypeNameUpside
StockAxoGen24.81%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks19.58%

Price Target Trends

1M3M12M
# Anlaysts61010
Avg Price Target$38.00$34.00$34.00
Last Closing Price$29.99$29.99$29.99
Upside/Downside26.71%13.37%13.37%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 2527---9
Nov, 2535---8
Oct, 2535---8
Sep, 2525---7
Aug, 2525---7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 05, 2025H.C. Wainwright$39.00$33.7015.73%30.04%
Dec 05, 2025Canaccord Genuity$37.00$32.8612.60%23.37%
Dec 04, 2025Jayson BedfordRaymond James$36.00$33.198.47%20.04%
Dec 04, 2025Frank TakkinenLake Street$40.00$32.1024.61%33.38%
Dec 04, 2025Jefferies$36.00$28.3327.07%20.04%
Dec 01, 2025Mizuho Securities$40.00$28.6539.62%33.38%
Oct 30, 2025H.C. Wainwright$26.00$22.8613.74%-13.30%
Oct 30, 2025Canaccord Genuity$27.00$22.2521.35%-9.97%
Oct 30, 2025JMP Securities$34.00$22.2552.81%13.37%
Sep 30, 2025Yi ChenH.C. Wainwright$25.00$17.2644.84%-16.64%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 05, 2025H.C. WainwrightBuyBuyhold
Dec 04, 2025Raymond JamesOutperformOutperformhold
Dec 04, 2025Lake StreetBuyBuyhold
Dec 04, 2025JefferiesBuyBuyhold
Oct 30, 2025H.C. WainwrightBuyBuyhold
Oct 30, 2025CitigroupOutperformOutperformhold
Oct 30, 2025CitigroupMarket OutperformMarket Outperformhold
Oct 29, 2025JefferiesBuyBuyhold
Sep 30, 2025H.C. WainwrightBuyinitialise
Jul 01, 2024Raymond JamesOutperforminitialise

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.62$-0.68$-0.65$-0.51$-0.23----
Avg Forecast$-0.43$-0.45$-0.38$-0.18$0.08$0.32$0.50$0.80$1.03
High Forecast$-0.43$-0.45$-0.38$-0.10$0.09$0.41$1.34$0.82$1.05
Low Forecast$-0.44$-0.46$-0.39$-0.30$0.06$0.17$-0.03$0.79$1.01
Surprise %44.19%51.11%71.05%183.33%-387.50%----

Revenue Forecast

$100M $150M $200M $250M $300M $350M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$112.30M$127.36M$138.58M$159.01M$187.34M----
Avg Forecast$110.08M$127.56M$138.65M$157.75M$186.09M$210.10M$236.14M$271.40M$303.65M
High Forecast$111.26M$128.93M$139.92M$160.54M$187.34M$212.44M$236.98M$275.90M$309.02M
Low Forecast$109.20M$126.54M$137.46M$155.86M$184.84M$208.32M$235.30M$266.90M$300.02M
Surprise %2.01%-0.16%-0.05%0.80%0.67%----

Net Income Forecast

$-50M $-20M $10M $40M $70M $100M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-24.80M$-28.06M$-27.34M$-21.72M$-9.96M----
Avg Forecast$-28.77M$-32.48M$-35.74M$-21.72M$3.12M$12.48M$18.07M$34.43M$44.16M
High Forecast$-23.02M$-25.98M$-28.59M$-17.37M$3.67M$17.52M$57.62M$35.09M$45.18M
Low Forecast$-34.53M$-38.97M$-42.89M$-26.06M$2.57M$7.45M$-1.46M$33.77M$43.48M
Surprise %-13.80%-13.59%-23.52%--419.06%----

AXGN Forecast FAQ

Is AxoGen stock a buy?

AxoGen stock has a consensus rating of Buy, based on 18 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 15 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that AxoGen is a favorable investment for most analysts.

What is AxoGen's price target?

AxoGen's price target, set by 18 Wall Street analysts, averages $37.43 over the next 12 months. The price target range spans from $34 at the low end to $40 at the high end, suggesting a potential 24.81% change from the previous closing price of $29.99.

How does AxoGen stock forecast compare to its benchmarks?

AxoGen's stock forecast shows a 24.81% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (19.58%).

What is the breakdown of analyst ratings for AxoGen over the past three months?

  • December 2025: 22.22% Strong Buy, 77.78% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 37.50% Strong Buy, 62.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 37.50% Strong Buy, 62.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is AxoGen’s EPS forecast?

AxoGen's average annual EPS forecast for its fiscal year ending in December 2025 is $0.32, marking a -239.13% decrease from the reported $-0.23 in 2024. Estimates for the following years are $0.5 in 2026, $0.8 in 2027, and $1.03 in 2028.

What is AxoGen’s revenue forecast?

AxoGen's average annual revenue forecast for its fiscal year ending in December 2025 is $210.1M, reflecting a 12.15% increase from the reported $187.34M in 2024. The forecast for 2026 is $236.14M, followed by $271.4M for 2027, and $303.65M for 2028.

What is AxoGen’s net income forecast?

AxoGen's net income forecast for the fiscal year ending in December 2025 stands at $12.48M, representing a -225.28% decrease from the reported $-9.964M in 2024. Projections indicate $18.07M in 2026, $34.43M in 2027, and $44.16M in 2028.